REGENXBIO INC's ticker is RGNX and the CUSIP is 75901B107. A total of 3 filers reported holding REGENXBIO INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $6,090 | -17.7% | 370 | 0.0% | 0.00% | – |
Q2 2023 | $7,396 | +5.7% | 370 | 0.0% | 0.00% | – |
Q1 2023 | $6,997 | +87362.5% | 370 | 0.0% | 0.00% | – |
Q4 2022 | $8 | -99.9% | 370 | 0.0% | 0.00% | – |
Q3 2022 | $10,000 | +11.1% | 370 | 0.0% | 0.00% | – |
Q2 2022 | $9,000 | -25.0% | 370 | 0.0% | 0.00% | – |
Q1 2022 | $12,000 | 0.0% | 370 | 0.0% | 0.00% | – |
Q4 2021 | $12,000 | – | 370 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Aquilo Capital Management, LLC | 839,139 | $35,177,000 | 6.39% |
Sonic Fund II, L.P. | 188,786 | $7,914,000 | 4.47% |
ArchPoint Investors | 297,355 | $12,465,000 | 3.73% |
Redmile Group, LLC | 2,008,001 | $84,175,000 | 1.47% |
RTW INVESTMENTS, LP | 1,845,366 | $77,358,000 | 1.17% |
WS MANAGEMENT LLLP | 210,729 | $8,834,000 | 0.94% |
FRAZIER MANAGEMENT LLC | 235,809 | $9,885,000 | 0.79% |
Integral Health Asset Management, LLC | 55,000 | $2,306,000 | 0.66% |
Sofinnova Investments, Inc. | 127,593 | $5,349,000 | 0.32% |
HHLR ADVISORS, LTD. | 456,000 | $19,116,000 | 0.25% |